Bio-Rad Laboratories vs Molina Healthcare

Bio-Rad Laboratories (BIO), health care, and Molina Healthcare (MOH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Molina Healthcare is worth $11.5B on the stock market and Bio-Rad Laboratories $9.6B: Molina Healthcare is valued at 20% more. Bio-Rad Laboratories's operating margin in its latest fiscal year was 1.83% and Molina Healthcare's 1.72%. Over the past year Bio-Rad Laboratories's share price has moved +17.1% and Molina Healthcare's +65.1%.

Key facts

Bio-Rad Laboratories market value
$9.6B
Molina Healthcare market value
$11.5B
Bio-Rad Laboratories P/E
9.5
Bio-Rad Laboratories revenue
$2.6BFY to 2025-12-31
Molina Healthcare revenue
$45.4BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Bio-Rad Laboratories vs Molina Healthcare: every measure side by side
Measure Bio-Rad Laboratories Molina Healthcare
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$9.6Blower$11.5Bhigher
Revenue$2.6Blower$45.4Bhigher
Earnings$759.9Mhigher$472Mlower
Employees7,450lower19,000higher
Total assets$10.6Blower$15.6Bhigher
Valuation
P/E9.5—
P/S3.7higher0.3lower
P/B1.3lower2.8higher
Dividend yield0.00%0.00%
Profitability
Operating margin1.83%higher1.72%lower
Balance sheet
Net assets$7.5Bhigher$4.1Blower
Total liabilities$3.1Blower$11.5Bhigher
Total debt$1.2Blower$3.8Bhigher
Cash on hand$529.8Mlower$4.2Bhigher
Price change
Today-0.57%higher-5.10%lower
1 year+17.1%lower+65.1%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Bio-Rad Laboratories only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns BIO · Who owns MOH

Further comparisons

Learn

Questions and answers

Which is bigger, Bio-Rad Laboratories or Molina Healthcare?

By market value, Molina Healthcare is the larger: $11.5B against $9.6B for Bio-Rad Laboratories. By revenue in its latest fiscal year, Molina Healthcare is the larger: $45.4B against $2.6B for Bio-Rad Laboratories.

Which has the higher operating margin?

Bio-Rad Laboratories: 1.83%, against 1.72% for Molina Healthcare. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Molina Healthcare: $3.8B, against $1.2B for Bio-Rad Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Bio-Rad Laboratories and Molina Healthcare?

None of the tracked superinvestors holds both in their latest 13F filing. 3 hold Bio-Rad Laboratories and 4 hold Molina Healthcare.

Cite this page

Funkfolio, “Bio-Rad Laboratories vs Molina Healthcare”, data as of 17 November 2026. https://funkfolio.com/compare/bio-vs-moh

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.